Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 2013, with the report dated April 17, 2013. The filing serves as a notification of transactions involving directors or persons discharging managerial responsibility, specifically regarding the GlaxoSmithKline US Deferred Performance Share Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory notification of a specific share transaction rather than a financial performance report.
Material Changes
The filing reports a specific increase in the American Depositary Shares (ADSs) held by Mr. D E Troy. The transaction details are as follows:
- Transaction Type: Increase in interest via dividend re-investment.
- Shares Acquired: 353.312 ADSs.
- Price per ADS: $48.52.
- Dividend Date: April 11, 2013.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of the director's share transaction in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
Investor Verification Checklist
- Verify the total shareholding of Mr. D E Troy following this transaction.
- Confirm the dividend payment date of April 11, 2013, and the associated payout amount.
- Review the terms of the GlaxoSmithKline US Deferred Performance Share Plan regarding dividend re-investment.
- Check for other concurrent Form 6-K filings for the same period to assess broader corporate activity.